6th Guide to German Medtech Companies 2021

The medical technology sector is currently experiencing one of its most challenging times. While medtech constitutes a well-established pillar within the healthcare in- dustry in Germany and provides a lot to the country's export-driven economic growth, the pandemic has changed business activities fundamentally in 2020 and will con- tinue to do so in 2021. But thanks to the strong growth periods of recent years, Ger- man companies are nevertheless in a good position to pull through a period of tur- bulence and tough requirements - be it due to the corona pandemic or with regard to the regulatory situation. Seen from this perspective, the German medtech sector is still faring comparably well. For 2020, around 32 billion euros of revenue will be generated - less than 2019, but still more than in 2018. The robust condition of the sector owes to the very German-like combination of tradition and inventiveness, focus on quality and ef cient engineering expertise, resulting in the continuous development of new products as well as a good hands-on mentality in dealing with an unprecedent crisis. Another of the sector's competences which helped to provide stable business activities is its ability to cross-link with the pharma, IT, and manufacturing sectors. With the sixth edition of our "Guide to German Medtech Companies", BIOCOM AG follows this development, highlighting the broad competences of the German medical technology sector. The Guide offers a diverse compendium of companies - from medical device developers to manufacturers, service providers, medtech event organisers and organisations. In addition, the most recent trends in the German medtech sector are summarised in the introduction, for instance digitisation. The Guide to German Medtech Companies is supported by our partners Germany Trade & Invest, BVMed e.V., Medical Valley EMN e.V., Life Science Nord, Medical Mountains, SPECTARIS, Forum MedTech Pharma, MicroTec Su¿dwest, IVAM, and VDMA. These national organisations and regional networks are important stakehold- ers, helping to establish further growth of "medtech made in Germany" by providing the right environment for traditional family-owned rms, global players, start-ups, technological forerunners, manufacturers, suppliers, and service providers. As this book will be distributed digitally and with the support of many interna- tional medtech stakeholders in Europe and overseas, it will de nitely provide strong visibility of German medical technology companies on an international level. The publication is also available for free via our BIOCOM AG app. Electronic version or as printed copy: the Guide is bound to become a must-have on the desk of health professionals in Germany and beyond.